Rare Lung Disease Research
| Autor: | Koyeli Banerjee, Neil R. Aggarwal, Louis J. Vuga, Roya Kalantari, James P. Kiley, Lora A. Reineck |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Pulmonary and Respiratory Medicine
Government medicine.medical_specialty business.industry Public-Private Sector Partnership Critical Care and Intensive Care Medicine medicine.disease Idiopathic pulmonary fibrosis Lung disease General partnership Lymphangioleiomyomatosis medicine Observational study Cardiology and Cardiovascular Medicine business Intensive care medicine |
| Zdroj: | Chest. 156:438-444 |
| ISSN: | 0012-3692 |
| DOI: | 10.1016/j.chest.2019.05.004 |
| Popis: | The NHLBI’s DLD oversees research programs encompassing numerous rare lung diseases and is firmly committed to supporting research across the spectrum of basic science to clinical observational studies and interventional trials conducted by investigators at all career stages. Although most rare lung diseases research funded by the DLD stems from investigator-initiated applications in response to parent funding opportunity announcements, several successful institute-initiated rare lung diseases research programs demonstrate the DLD’s sustained commitment toward improving outcomes in rare lung diseases. With the promise of exciting technologic advances, the existence of novel funding opportunities for a cadre of skilled investigators, and the collaborative efforts of relevant advocacy groups and consortia, the goal to accelerate scientific research and improve outcomes in rare lung diseases is being realized. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|